Francesco Salvo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

British journal of clinical pharmacology

Pharmaceuticals (Basel, Switzerland)

Fundamental & clinical pharmacology

Antibiotics (Basel, Switzerland)

Université de Bordeaux

Università degli Studi di Messina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Bordeaux Sep 01 2017

France

Associate Professor of Pharmacology

Education History

Università degli Studi di Messina Sep 01 1996 - Dec 10 2009

Italy

PHD

Publications

Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Francesco Salvo, Joelle Micallef, Amir Lahouegue, Laurent Chouchana, Louis Létinier, Jean-Luc Faillie, Antoine Pariente
Will the future of pharmacovigilance be more automated? Expert opinion on drug safety (2023)
Alemayehu Lelisa Duga, Francesco Salvo, Alexander W Kay, Albert Figueras
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase ® ). Antibiotics (Basel, Switzerland) 12 (5) (2023)
Amélie Daveluy, Michael Charles Bryan, Ghada Miremont-Salamé, Régis Lassalle, Clémentine Lacueille, Angela Grelaud, Marie Floccia, Françoise Haramburu, Maryse Lapeyre Mestre, Joëlle Micallef, Francesco Salvo
Analgesic switching in chronic users of dextropropoxyphene in France. Fundamental & clinical pharmacology (2023)
Fabrizio Calapai, Carmen Mannucci, Liana McQuain, Francesco Salvo
Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Justine Perino, Virginie Corand, Elise Laurent, Hélène Théophile, Ghada Miremont-Salamé, Antoine Pariente, Jean-Laurent Colas, Thierry Couffinhal, Francesco Salvo
Myocardial infarction associated with erenumab: A case report. Pharmacotherapy 42 (7) (2022)
Laure-Hélène Préta, Adrien Contejean, Francesco Salvo, Jean Marc Treluyer, Caroline Charlier, Laurent Chouchana
Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273). British journal of clinical pharmacology 88 (7) (2022)
Guillaume Moulis, Etienne Crickx, Laure Thomas, Nathalie Massy, Matthieu Mahévas, Marie-Blanche Rabier, Marina Atzenhoffer, Marc Michel, Bertrand Godeau, Haleh Bagheri, Francesco Salvo, null null
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring. Blood 139 (16) (2022)
Delphine Bourneau-Martin, Marina Babin, Aurélie Grandvuillemin, Charlotte Mullet, Francesco Salvo, Allison Singier, Morgane Cellier, Audrey Fresse, Claire de Canecaude, Tessa Pietri, Guillaume Drablier, Hélène Geniaux, Laurence Lagarce, Marie Laure Laroche, Rodolphe Perrot, null null
Adverse drug reaction related to drug shortage: A retrospective study on the French National Pharmacovigilance Database. British journal of clinical pharmacology (2022)
Andrea Spini, Valerio Ciccone, Pietro Rosellini, Marina Ziche, Ersilia Lucenteforte, Francesco Salvo, Sandra Donnini
Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis. Cancers 14 (21) (2022)
Emanuel Raschi, Francesco Salvo, Charles Khouri
Conceiving, conducting, reporting, interpreting, and publishing disproportionality analyses: A call to action. British journal of clinical pharmacology 88 (7) (2022)
Kilian Trin, Justine Perino, Marion Allouchery, Hélène Géniaux, Ghada Miremont, Francesco Salvo
Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: A case report. Pain practice : the official journal of World Institute of Pain (2022)
Allison Singier, Pernelle Noize, Driss Berdaï, Amélie Daveluy, Mickaël Arnaud, Mathieu Molimard, Bernard Bégaud, Francesco Salvo
Medicine misuse: A systematic review and proposed hierarchical terminology. British journal of clinical pharmacology 87 (4) (2020)
Marion Allouchery, Cécile Tomowiak, Stéphanie Guidez, Vincent Delwail, Paul Delaunay, Claire Lafay-Chebassier, Francesco Salvo, Marie-Christine Pérault-Pochat
Patterns of use and safety of ibrutinib in real-life practice. British journal of clinical pharmacology 87 (3) (2020)
Emilie Casarotto, Pernelle Noize, Louis Létinier, Francesco Salvo, Anne Pham-Ledard, Mathieu Molimard
Safety profile of drugs for advanced melanoma: A report based on 2008-2018 US Food and Drug Administration Data. British journal of clinical pharmacology 87 (7) (2020)

Francesco Salvo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francesco Salvo